Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias

NCT04297891 is registered in ClinicalTrials.gov with Dr. Rebecca Schule as lead sponsor.

NCT NCT04297891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04297891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias
Lead sponsor
Dr. Rebecca Schule
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2020
Completion date
June 30, 2025
Enrollment
250 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

spastic ataxia